About
Small Molecule Antivirals
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (21)
View allTotal Trials
21
As Lead Sponsor
21
As Collaborator
0
Total Enrollment
1,314
By Phase
PHASE1: 13PHASE2: 7PHASE1/PHASE2: 1
By Status
COMPLETED: 12TERMINATED: 6RECRUITING: 3
Clinical Trials Pipeline21 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06740474Lead Sponsor
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants
PHASE1Recruiting
78 participants
Started: Jan 31, 2025 · Completed: Aug 31, 2025
NCT06698575Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes
PHASE1Recruiting
146 participants
Started: Dec 8, 2024 · Completed: Dec 31, 2025
NCT06384131Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
PHASE1Completed
20 participants
Started: Jun 4, 2024 · Completed: May 14, 2025
NCT06385327Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes
PHASE1Recruiting
146 participants
Started: May 30, 2024 · Completed: Dec 31, 2025
NCT05569941Lead Sponsor
A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects
PHASE1Completed
54 participants
Started: Nov 11, 2022 · Completed: Apr 12, 2023
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...